🇺🇸 FDA

Company profile · Sponsor

CSL

CSL Behring GmbH

E68D380 · EMA pharma Marburg, DE
Pipeline
7
Drugs
0
Patents
0

Quick answer

CSL (E68D380) is a pharma company. headquartered in Marburg, DE. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E68D380
Exchange EMA
Company type pharma
Headquarters Marburg, DE

Pipeline (7)

Search pipeline →

  1. BE1116

    CSL

    Complex Cardiovascular Surgery With Cardiopulmonary Bypass

    phase 3 mab active

    1 trial

  2. CSL689

    CSL

    Hemophilia A With Inhibitors

    phase 3 small molecule terminated

    1 trial

  3. Clazakizumab

    CSL

    Antibody-mediated Rejection

    phase 3 mab terminated

    1 trial

  4. human immunoglobulin G

    CSL

    Dermatomyositis

    phase 3 small molecule terminated

    1 trial

  5. ALD518

    CSL

    Oral Mucositis

    phase 2 mab terminated

    1 trial

  6. BMS-945429 Placebo

    CSL

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  7. CSL760

    CSL

    Coronavirus Disease 2019 (COVID-19)

    phase 1 mab terminated

    1 trial

Frequently asked questions

What is CSL?

CSL (E68D380) is a pharma company. headquartered in Marburg, DE. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does CSL sponsor?

We track 7 ClinicalTrials.gov-linked programs for CSL, including BE1116 and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does CSL company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.